Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US9795567B2 · kind B2 · utility
54Cited by
28References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2014 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Jun 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.